PubRank

Paul A James

Author PubWeight™ 55.80‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009 5.75
2 Breast-cancer risk in families with mutations in PALB2. N Engl J Med 2014 4.97
3 The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med 2009 4.10
4 Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet 2013 2.39
5 Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles. PLoS Genet 2012 1.84
6 A role for common genomic variants in the assessment of familial breast cancer. J Clin Oncol 2012 1.80
7 Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature. Hypertension 2004 1.70
8 Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 2013 1.55
9 Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. J Med Genet 2010 1.50
10 Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Hum Mutat 2011 1.38
11 Generalist solutions to complex problems: generating practice-based evidence--the example of managing multi-morbidity. BMC Fam Pract 2013 1.34
12 Explicit and implicit evaluation of physician adherence to hypertension guidelines. J Clin Hypertens (Greenwich) 2007 1.31
13 Colorectal cancer testing among patients cared for by Iowa family physicians. Am J Prev Med 2006 1.30
14 A cluster-randomized effectiveness trial of a physician-pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes 2010 1.26
15 A mutation in the small heat-shock protein HSPB1 leading to distal hereditary motor neuronopathy disrupts neurofilament assembly and the axonal transport of specific cellular cargoes. Hum Mol Genet 2005 1.21
16 Why hasn't this patient been screened for colon cancer? An Iowa Research Network study. J Am Board Fam Med 2007 1.13
17 Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk. Nat Genet 2012 1.10
18 The limited effect of screening for depressive symptoms with the PHQ-9 in rural family practices. J Rural Health 2005 1.04
19 A systematic review of studies comparing myocardial infarction mortality for generalists and specialists: lessons for research and health policy. J Am Board Fam Med 2006 1.03
20 An assessment of attitudes, behaviors, and outcomes of patients with type 2 diabetes. J Am Board Fam Med 2009 1.02
21 Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy. FEBS Lett 2007 1.00
22 Extending the scope of diagnostic chromosome analysis: detection of single gene defects using high-resolution SNP microarrays. Hum Mutat 2011 0.99
23 The Iowa Continuity of Care study: Background and methods. Am J Health Syst Pharm 2008 0.96
24 Rare variants in XRCC2 as breast cancer susceptibility alleles. J Med Genet 2012 0.94
25 Phenotypic variability of distal 22q11.2 copy number abnormalities. Am J Med Genet A 2011 0.93
26 Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial. J Clin Hypertens (Greenwich) 2013 0.91
27 BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. J Natl Cancer Inst 2015 0.90
28 Empirically identified goals for the management of unexplained symptoms. Fam Med 2006 0.90
29 A model for diversity in admissions: a review of issues and methods and an experimental approach. Teach Learn Med 2003 0.88
30 Analysis of RAD51D in ovarian cancer patients and families with a history of ovarian or breast cancer. PLoS One 2013 0.86
31 Perceptions of Iowa family physicians regarding colorectal cancer screening. Med Care 2008 0.86
32 Effect of a care transition intervention by pharmacists: an RCT. BMC Health Serv Res 2014 0.85
33 Let's Not SPRINT to Judgment About New Blood Pressure Goals. Ann Intern Med 2016 0.84
34 Brugada syndrome caused by a large deletion in SCN5A only detected by multiplex ligation-dependent probe amplification. J Cardiovasc Electrophysiol 2011 0.84
35 The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia. Fam Cancer 2013 0.82
36 Copy-number variation associated with congenital anomalies of the kidney and urinary tract. Pediatr Nephrol 2014 0.81
37 BRCA and beyond: a genome-first approach to familial breast cancer risk assessment. Discov Med 2011 0.77
38 Partial tetrasomy 15 due to a unique inverted triplication of chromosome15q24-q26. Am J Med Genet A 2004 0.76
39 Exercise capacity and the risk of death in women. Circulation 2004 0.75
40 Family Medicine Research in the United States From the late 1960s Into the Future. Fam Med 2017 0.75
41 Breast conservation versus mastectomy in triple-negative breast cancer: two steps forward, one step back? J Clin Oncol 2011 0.75
42 Specialty of ambulatory care physicians and mortality after myocardial infarction. N Engl J Med 2003 0.75
43 Clinical problem-solving. Spot diagnosis. N Engl J Med 2014 0.75
44 Interdisciplinary education for genetic counselors: developing the concept and assessing the need in australasia. J Genet Couns 2014 0.75
45 Implementation of a diabetes management program for patients in a rural primary care office. J Prim Care Community Health 2011 0.75
46 Molecular diagnosis in a pregnancy at risk for both spondyloepiphyseal dysplasia congenita and achondroplasia. Prenat Diagn 2003 0.75
47 An empirical validity study of a preceptor evaluation instrument. Acad Med 2002 0.75
48 A cooperative experience in rural health education for medical students. J Agromedicine 2004 0.75